Reaction
Bacteriuria reporting signals
As of the last recalculation, Bacteriuria appears in 550 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 119.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 55 | 119.5 | 119.8 |
| Anti-Thymocyte Globulin (Rabbit) | 12 | 57.5 | 57.6 |
| Valganciclovir Hydrochloride Powder, | 16 | 51.1 | 51.2 |
| Micafungin Sodium | 9 | 40.8 | 40.9 |
| Valganciclovir | 18 | 37.3 | 37.4 |
| Valganciclovir Hydrochloride | 18 | 37.3 | 37.4 |
| Alpelisib | 4 | 17.5 | 17.5 |
| Sevelamer Carbonate | 5 | 16.6 | 16.6 |
| Polatuzumab Vedotin | 4 | 15.6 | 15.6 |
| Tapentadol Hydrochloride | 7 | 8.0 | 8.0 |